Average Co-Inventor Count = 6.96
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Sanofi (20 from 1,454 patents)
2. Sanof Aventis (1 from 1 patent)
21 patents:
1. 11453727 - Antibodies that bind IL-4 and/or IL-13 and their uses
2. 10759871 - Antibodies that bind IL-4 and/or IL-13 and their uses
3. 10112991 - Humanized antibodies specific to the protofibrillar form of the beta-amyloid peptide
4. 9815902 - Humanized anti-CXCR5 antibodies, derivatives thereof and their uses
5. 9738728 - Antibodies that bind IL-4 and/or IL-13 and their uses
6. 9732162 - Antibodies that bind IL-4 and/or IL-13 and their uses
7. 9676864 - Antibodies that specifically bind to the EphA2 receptor
8. 9441040 - Antagonist antibodies and their fab fragments against GPVI and uses thereof
9. 9382312 - Humanized antibodies specific to the protofibrillar form of the beta-amyloid peptide
10. 9243067 - Humanized anti-CXCR5 antibodies, derivatives thereof and their use
11. 9228019 - Humanized anti-CXCR5 antibodies, derivatives thereof and their use
12. 9221917 - Dual variable region antibody-like binding proteins having cross-over binding region orientation
13. 9181349 - Dual variable region antibody-like binding proteins having cross-over binding region orientation
14. 9175087 - Humanized anti-CXCR5 antibodies, derivatives thereof and their use
15. 8980262 - Humanized anti-CXCR5 antibodies, derivatives thereof and their use